A single night of sleep curtailment increases plasma acylcarnitines: Novel insights in the relationship between sleep and insulin resistance

Archives of Biochemistry and Biophysics

Volumn 589, Issue , 2016, Pages 145-151

  Van Den Berg, Rosa ^a   Mook Kanamori, Dennis O ^a,b   Donga, Esther ^a   Van Dijk, Marieke ^a   Van Dijk, J Gert ^a   Lammers, Gert Jan ^a   Van Kralingen, Klaas W ^a   Prehn, Cornelia ^c   Adamski, Jerzy ^c,d,e   Romijn, Johannes A ^f   Willems Van Dijk, Ko ^a   Corssmit, Eleonora P M ^a   Rensen, Patrick C N ^a   Biermasz, Nienke R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Acylcarnitines; Diabetes; Insulin resistance; Metabolomics; Sleep deprivation; Sleep loss

Indexed keywords

ACYLCARNITINE; CARNITINE DERIVATIVE; OCTADECADIENYL LEVO CARNITINE; OCTADECANOYL LEVO CARNITINE; TETRADECENOYL LEVO CARNITINE; UNCLASSIFIED DRUG; CARNITINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MALE; METABOLOMICS; PRIORITY JOURNAL; SLEEP TIME; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; DIET RESTRICTION; SLEEP;

ADULT; CARNITINE; FASTING; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLOMICS; SLEEP;

EID: 84950326822     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2015.09.017     Document Type: Article

References (51)

1. J.J. Chillaron, J.A. Flores Le-Roux, D. Benaiges, and J. Pedro-Botet Type 1 diabetes, metabolic syndrome and cardiovascular risk Metabolism 63 2014 181 187
2. K.M. Fox, Y. Wu, J. Kim, and S. Grandy Cardiovascular event rates and healthcare resource utilisation among high-risk adults with type 2 diabetes mellitus in a large population-based study Int. J. Clin. Pract. 69 2015 218 227
3. E. Donga, O.M. Dekkers, E.P. Corssmit, and J.A. Romijn Insulin resistance in patients with type 1 diabetes assessed by glucose clamp studies: systematic review and meta-analysis Eur. J. Endocrinol. 173 2015 101 109
4. R. Leproult, and C.E. Van Role of sleep and sleep loss in hormonal release and metabolism Endocr. Dev. 17 2010 11 21
5. F.P. Cappuccio, L. D'Elia, P. Strazzullo, and M.A. Miller Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis Diabetes Care 33 2010 414 420
6. A.L. Borel, J.L. Pepin, L. Nasse, J.P. Baguet, S. Netter, and P.Y. Benhamou Short sleep duration measured by wrist actimetry is associated with deteriorated glycemic control in type 1 diabetes Diabetes Care 36 2013 2902 2908
7. O.M. Buxton, and E. Marcelli Short and long sleep are positively associated with obesity, diabetes, hypertension, and cardiovascular disease among adults in the United States Soc. Sci. Med. 71 2010 1027 1036
8. Y. Liu, J.B. Croft, A.G. Wheaton, G.S. Perry, D.P. Chapman, T.W. Strine, L.R. McKnight-Eily, and L. Presley-Cantrell Association between perceived insufficient sleep, frequent mental distress, obesity and chronic diseases among US adults, 2009 behavioral risk factor surveillance system BMC Public Health 13 2013 84
9. J. Najafian, N. Mohamadifard, Z.D. Siadat, G. Sadri, and M.R. Rahmati Association between sleep duration and diabetes mellitus: Isfahan Healthy Heart Program Niger. J. Clin. Pract. 16 2013 59 62
10. T. Ohkuma, H. Fujii, M. Iwase, Y. Kikuchi, S. Ogata, Y. Idewaki, H. Ide, Y. Doi, Y. Hirakawa, U. Nakamura, and T. Kitazono Impact of sleep duration on obesity and the glycemic level in patients with type 2diabetes Diabetes Care 36 2013 611 617
11. A.V. Nedeltcheva, L. Kessler, J. Imperial, and P.D. Penev Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance J. Clin. Endocrinol. Metab. 94 2009 3242 3250
12. K. Spiegel, R. Leproult, and C.E. Van Impact of sleep debt on metabolic and endocrine function Lancet 354 1999 1435 1439
13. O.M. Buxton, M. Pavlova, E.W. Reid, W. Wang, D.C. Simonson, and G.K. Adler Sleep restriction for 1 week reduces insulin sensitivity in healthy men Diabetes 59 2010 2126 2133
14. E. Donga, D.M. van, J.G. van Dijk, N.R. Biermasz, G.J. Lammers, K.W. van Kralingen, E.P. Corssmit, and J.A. Romijn A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects J. Clin. Endocrinol. Metab. 95 2010 2963 2968
15. E. Donga, D.M. van, J.G. van Dijk, N.R. Biermasz, G.J. Lammers, K.K. van, R.P. Hoogma, E.P. Corssmit, and J.A. Romijn Partial sleep restriction decreases insulin sensitivity in type 1 diabetes Diabetes Care 33 2010 1573 1577
16. C. Gieger, L. Geistlinger, E. Altmaier, A.M. Hrabe de, F. Kronenberg, T. Meitinger, H.W. Mewes, H.E. Wichmann, K.M. Weinberger, J. Adamski, T. Illig, and K. Suhre Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum PLoS Genet. 4 2008 e1000282
17. K. Suhre Metabolic profiling in diabetes J. Endocrinol. 221 2014 R75 R85
18. L.N. Bell, J.M. Kilkus, J.N. Booth III, L.E. Bromley, J.G. Imperial, and P.D. Penev Effects of sleep restriction on the human plasma metabolome Physiol. Behav. 122 2013 25 31
19. A.M. Weljie, P. Meerlo, N. Goel, A. Sengupta, M.S. Kayser, T. Abel, M.J. Birnbaum, D.F. Dinges, and A. Sehgal Oxalic acid and diacylglycerol 36:3 are cross-species markers of sleep debt Proc. Natl. Acad. Sci. U. S. A. 112 2015 2569 2574
20. S.K. Davies, J.E. Ang, V.L. Revell, B. Holmes, A. Mann, F.P. Robertson, N. Cui, B. Middleton, K. Ackermann, M. Kayser, A.E. Thumser, F.I. Raynaud, and D.J. Skene Effect of sleep deprivation on the human metabolome Proc. Natl. Acad. Sci. U. S. A. 111 2014 10761 10766
21. R.A. DeFronzo, J.D. Tobin, and R. Andres Glucose clamp technique: a method for quantifying insulin secretion and resistance Am. J. Physiol. 237 1979 E214 E223
22. W. Römisch-Margl, C. Prehn, R. Bogumil, C. Röhring, K. Suhre, and J. Adamski Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics Metabolomics 8 2012 133 142
23. T. Illig, C. Gieger, G. Zhai, W. Romisch-Margl, R. Wang-Sattler, C. Prehn, E. Altmaier, G. Kastenmuller, B.S. Kato, H.W. Mewes, T. Meitinger, M.H. de Angelis, F. Kronenberg, N. Soranzo, H.E. Wichmann, T.D. Spector, J. Adamski, and K. Suhre A genome-wide perspective of genetic variation in human metabolism Nat. Genet. 42 2010 137 141
24. M. Mai, A. Tonjes, P. Kovacs, M. Stumvoll, G.M. Fiedler, and A.B. Leichtle Serum levels of acylcarnitines are altered in prediabetic conditions PLoS One 8 2013 e82459
25. S.J. Mihalik, B.H. Goodpaster, D.E. Kelley, D.H. Chace, J. Vockley, F.G. Toledo, and J.P. DeLany Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity Obesity (Silver Spring) 18 2010 1695 1700
26. M.G. Schooneman, F.M. Vaz, S.M. Houten, and M.R. Soeters Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes 62 2013 1 8
27. T.R. Koves, J.R. Ussher, R.C. Noland, D. Slentz, M. Mosedale, O. Ilkayeva, J. Bain, R. Stevens, J.R. Dyck, C.B. Newgard, G.D. Lopaschuk, and D.M. Muoio Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance Cell Metab. 7 2008 45 56
28. C. Chen, K.W. Krausz, Y.M. Shah, J.R. Idle, and F.J. Gonzalez Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity Chem. Res. Toxicol. 22 2009 699 707
29. Q. Xu, H. Vu, L. Liu, T.C. Wang, and W.H. Schaefer Metabolic profiles show specific mitochondrial toxicities in vitro in myotube cells J. Biomol. NMR 49 2011 207 219
30. M.R. Soeters, H.P. Sauerwein, M. Duran, R.J. Wanders, M.T. Ackermans, E. Fliers, S.M. Houten, and M.J. Serlie Muscle acylcarnitines during short-term fasting in lean healthy men Clin. Sci. (Lond.) 116 2009 585 592
31. P. Rinaldo, T.M. Cowan, and D. Matern Acylcarnitine profile analysis Genet. Med. 10 2008 151 156
32. F. Razak, and S.S. Anand Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. N Engl J Med 2004; 350: 664-71 Vasc. Med. 9 2004 223 224
33. K. Morino, K.F. Petersen, S. Dufour, D. Befroy, J. Frattini, N. Shatzkes, S. Neschen, M.F. White, S. Bilz, S. Sono, M. Pypaert, and G.I. Shulman Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents J. Clin. Invest. 115 2005 3587 3593
34. D.E. Befroy, K.F. Petersen, S. Dufour, G.F. Mason, R.A. de Graaf, D.L. Rothman, and G.I. Shulman Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients Diabetes 56 2007 1376 1381
35. D.E. Kelley, J. He, E.V. Menshikova, and V.B. Ritov Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes Diabetes 51 2002 2944 2950
36. V.B. Ritov, E.V. Menshikova, J. He, R.E. Ferrell, B.H. Goodpaster, and D.E. Kelley Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes Diabetes 54 2005 8 14
37. M. Mogensen, K. Sahlin, M. Fernstrom, D. Glintborg, B.F. Vind, H. Beck-Nielsen, and K. Hojlund Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes Diabetes 56 2007 1592 1599
38. M. Cree-Green, B.R. Newcomer, M.S. Brown, A.D. Baumgartner, B. Bergman, B. Drew, J.G. Regensteiner, L. Pyle, J.E. Reusch, and K.J. Nadeau Delayed skeletal muscle mitochondrial ADP recovery in youth with type 1 diabetes relates to muscle insulin resistance Diabetes 64 2015 383 392
39. D.M. Muoio, R.C. Noland, J.P. Kovalik, S.E. Seiler, M.N. Davies, K.L. DeBalsi, O.R. Ilkayeva, R.D. Stevens, I. Kheterpal, J. Zhang, J.D. Covington, S. Bajpeyi, E. Ravussin, W. Kraus, T.R. Koves, and R.L. Mynatt Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility Cell Metab. 15 2012 764 777
40. S.E. Reuter, and A.M. Evans Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects Clin. Pharmacokinet. 51 2012 553 572
41. M.G. Schooneman, N. Achterkamp, C.A. Argmann, M.R. Soeters, and S.M. Houten Plasma acylcarnitines inadequately reflect tissue acylcarnitine metabolism Biochim. Biophys. Acta 1841 2014 987 994
42. M.G. Schooneman, G.A. Ten Have, V.N. Van, S.M. Houten, N.E. Deutz, and M.R. Soeters Transorgan fluxes in a porcine model reveal a central role for liver in acylcarnitine metabolism Am. J. Physiol. Endocrinol. Metab. 309 2015 E256 E264
43. C.B. Newgard, J. An, J.R. Bain, M.J. Muehlbauer, R.D. Stevens, L.F. Lien, A.M. Haqq, S.H. Shah, M. Arlotto, C.A. Slentz, J. Rochon, D. Gallup, O. Ilkayeva, B.R. Wenner, W.S. Yancy Jr., H. Eisenson, G. Musante, R.S. Surwit, D.S. Millington, M.D. Butler, and L.P. Svetkey A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance Cell Metab. 9 2009 311 326
44. M.S. Thearle, N. Pannacciulli, S. Bonfiglio, K. Pacak, and J. Krakoff Extent and determinants of thermogenic responses to 24 hours of fasting, energy balance, and five different overfeeding diets in humans J. Clin. Endocrinol. Metab. 98 2013 2791 2799
45. C.M. Jung, E.L. Melanson, E.J. Frydendall, L. Perreault, R.H. Eckel, and K.P. Wright Energy expenditure during sleep, sleep deprivation and sleep following sleep deprivation in adult humans J. Physiol. 589 2011 235 244
46. L. Klingenberg, A. Sjodin, U. Holmback, A. Astrup, and J.P. Chaput Short sleep duration and its association with energy metabolism Obes. Rev. 13 2012 565 577
47. S.H. Adams, C.L. Hoppel, K.H. Lok, L. Zhao, S.W. Wong, P.E. Minkler, D.H. Hwang, J.W. Newman, and W.T. Garvey Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women J. Nutr. 139 2009 1073 1081
48. J.M. Rutkowsky, T.A. Knotts, K.D. Ono-Moore, C.S. McCoin, S. Huang, D. Schneider, S. Singh, S.H. Adams, and D.H. Hwang Acylcarnitines activate proinflammatory signaling pathways Am. J. Physiol. Endocrinol. Metab. 306 2014 E1378 E1387
49. C. Aguer, C.S. McCoin, T.A. Knotts, A.B. Thrush, K. Ono-Moore, R. McPherson, R. Dent, D.H. Hwang, S.H. Adams, and M.E. Harper Acylcarnitines: potential implications for skeletal muscle insulin resistance FASEB J. 29 2015 336 345
50. B.D. Harfmann, E.A. Schroder, and K.A. Esser Circadian rhythms, the molecular clock, and skeletal muscle J. Biol. Rhythms 30 2015 84 94
51. C.B. Peek, A.H. Affinati, K.M. Ramsey, H.Y. Kuo, W. Yu, L.A. Sena, O. Ilkayeva, B. Marcheva, Y. Kobayashi, C. Omura, D.C. Levine, D.J. Bacsik, D. Gius, C.B. Newgard, E. Goetzman, N.S. Chandel, J.M. Denu, M. Mrksich, and J. Bass Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice Science 342 2013 1243417